JMS Co

JMS Co Profit per Employee

The Profit per Employee of JMS Co (7702.T) as of Nov 2, 2026 is -138,761.06 JPY. In the previous year, Profit per Employee was 15,752.21 JPY — a change of -980.90% (lower).

Profit per Employee

-138,761.06JPY

YoY

-980.90%

Last updated:

Profit per Employee of JMS Co is 2026 -138,761.06 JPY. Profit per Employee of JMS Co was 2025 15,752.21 JPY. It decreases by -980.90% lower compared to the previous year.

The JMS Co Profit per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Profit per Employee
Date
Profit per Employee
Jan 1, 2019
205,309.73 JPY
Jan 1, 2020
349,911.50 JPY
Jan 1, 2021
307,256.64 JPY
Jan 1, 2022
146,194.69 JPY
Jan 1, 2023
49,734.51 JPY
Jan 1, 2024
-6,371.68 JPY
Jan 1, 2025
15,752.21 JPY
Jan 1, 2026
-138,761.06 JPY
The JMS Co Profit per Employee history
YEARProfit per EmployeeYoY
-138,761.06JPY-980.90%
15,752.21JPY-347.22%
-6,371.68JPY-112.81%
49,734.51JPY-65.98%
146,194.69JPY-52.42%
307,256.64JPY-12.19%
349,911.50JPY+70.43%
205,309.73JPY+83.84%
111,681.42JPY-46.62%
209,203.54JPY+56.76%
133,451.33JPY+442.45%
24,601.77JPY-32.85%
36,637.17JPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

JMS Co Stock analysis

What does JMS Co do? JMS Co., Ltd. generates revenue through the manufacture, sale, export, and import of medical devices and pharmaceuticals across its five geographical segments: Japan, Singapore, China, Philippines, and Germany. The company offers a range of products including infusion and nutrition products, dialysis products, surgery products, blood and cell products, and other related items. Key products such as infusion & transfusion sets, syringe pumps, surgical gowns, dialysis kits, peritoneal dialysate, microcatheters, and blood bags are sold to healthcare providers and institutions within these regions. The firm also provides maintenance services and other related services as part of its product portfolio. The company's primary customers are healthcare providers and institutions in Japan, Singapore, China, Philippines, and Germany, where it operates through its five geographical segments. These customers purchase medical equipment and drugs, including specific items like infusion & transfusion sets, dialysis kits, and surgical gowns. The firm's product lines are tailored to meet the needs of hospitals, clinics, and other medical facilities across its operational regions. JMS Co., Ltd. focuses on manufacturing and selling medical equipment and drugs, with a strong emphasis on products such as infusion & transfusion sets, syringe pumps, surgical gowns, and dialysis kits. The company's revenue streams are driven by the sale of these products and the provision of maintenance services. Its geographical segments ensure a diversified market presence, allowing it to serve various healthcare sectors in different countries. JMS Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JMS Co stock

Profit per Employee of JMS Co is -138,761.06 JPY in 2026.

Profit per Employee of JMS Co changed from 15,752.21 JPY to -138,761.06 JPY, representing a -980.90% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Profit per Employee JMS Co since 2006 – with annual values, charts, and detailed analysis.

Profit per employee measures how much net income each employee generates on average. It is a key indicator of workforce efficiency.

Profit per Employee's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Profit per Employee's JMS Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — JMS Co

All Key Metrics — JMS Co